Partner Headlines - BMRN

  1. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  2. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  3. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  4. UPDATE: Stifel Nicolaus Upgrades BioMarin Pharmaceutical ...

    Benzinga

  5. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  6. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  7. J.P. Morgan Reiterates Overweight Rating, $60 PT on ...

    Benzinga

  8. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  9. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  10. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  11. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  12. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  13. UPDATE: Wedbush Reiterates BioMarin Pharmaceuticals at ...

    Benzinga

  14. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  15. BioMarin, Prestige Brands and Other Top Performing ...

    Benzinga

  16. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  17. Weekly Top Insider Sells? AAPL, GILD, BMRN, and PCLN

    GuruFocus

  18. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  19. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  20. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  21. Myriad Genetics Stock Hits High On Earnings Beat

    Investors Business Daily

  22. Highs & Lows: BioMarin Pharmaceutical, Best Buy, and ...

    By SchaeffersResearch

  23. BioMarin soars on drug data

    Investors Business Daily

  24. Mid-Afternoon Market Update: Markets Rally, Vringo Jumps

    Benzinga

  25. UPDATE: Canaccord Genuity Raises PT to $56 on BioMarin ...

    Benzinga

  26. Mid Morning Market Update: Markets Decline, Stifel ...

    Benzinga

  27. Stocks Hitting 52-Week Highs

    Benzinga

  28. BioMarin Stock Soars On Positive Drug Data

    Investors Business Daily

  29. BioMarin Phase 3 Study of GALNS Meets Primary Endpoint

    Benzinga

  30. Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  31. BioMarin Pharmaceutical Inc. Reports Operating Results ...

    GuruFocus

  32. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  33. UPDATE: Jefferies Raises PT to $46 on BioMarin ...

    Benzinga

  34. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  35. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  36. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  37. Health Care Sector Wrap

    FOXBusiness

  38. Benzinga's Top Downgrades

    Benzinga

  39. Biotechs In Motion As New Drug Pipeline Brims

    Investors Business Daily

  40. BioMarin Pharmaceutical Reports Inducement Grants Under ...

    Benzinga

  41. Dendreon, Pharmacyclics and Other Biotech Takeover Targets

    Benzinga

  42. BioMarin Pharmaceutical, Health Net Among Stocks Up on ...

    FOXBusiness

  43. Merck &, Questcor Pharmaceuticals, Other Stocks Hit ...

    FOXBusiness

  44. Amylin Pharmaceuticals, Constellation Brands Among ...

    FOXBusiness

  45. Analyst Initiations: BMRN, FB, and MDVN

    By SchaeffersResearch

  46. Benzinga's Top Pre-Market Gainers

    Benzinga

  47. From Earlier: Wedbush Reiterates BioMarin ...

    Benzinga

  48. Benzinga's Morning Initiation Summary for June 1, 2012

    Benzinga

  49. BioMarin Pharmaceutical (BMRN) Loses 7.2% After Pricing ...

    At Market Intelligence Center

  50. BioMarin Announces Pricing of Public Offering of Common ...

    Benzinga

  51. UPDATE: Citi Raises BioMarin Pharmaceuticals' PT

    Benzinga

  52. BioMarin Pharmaceutical (BMRN) Loses 1.3% as Volatility ...

    At Market Intelligence Center

  53. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques ...

    GuruFocus

  54. 5 Resilient Biotech Stocks to Buy for 2012

    at GuruFocus

  55. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques ...

    at GuruFocus

  56. BioMarin Pharmaceutical Inc. (BMRN) SVP, CFO Jeffrey H ...

    at GuruFocus

  57. BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques ...

    at GuruFocus

  58. Upgrades & Downgrades: YHOO, BMRN, HGSI, DNDN, and TSLA

    By SchaeffersResearch

  59. Just What The Doctor Ordered: 4 ETFs For Biotech M&A

    at Benzinga

  60. BioMarin Pharmaceutical Inc. (BMRN) SVP, CFO Jeffrey H ...

    at GuruFocus

  61. Stocks at New Highs: BioMarin Pharmaceutical and Seattle ...

    By SchaeffersResearch

  62. Call Volume Spikes on BioMarin Pharmaceutical

    By SchaeffersResearch
Marketplace
Trading Center